Angela is a pharmacist with an additional master's degree in health economics. For the past six years, Angela has been focusing on market access challenges. Starting at Novartis, she worked across various therapeutic areas such as neurology, dermatology, respiratory, and cardiac diseases. Currently, at Gilead/Kite, Angela is concentrating on CAR-T and cell therapy in the Netherlands. She also serves as President of the Young Innovators of Medicines, representing young professionals in the pharmaceutical industry and advocating for sustainability within the field.